Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
NCT02302742 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2025-10-06
Summary
PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
Conditions
- Breast Cancer
- Hereditary Breast and Ovarian Cancer
Sponsors & Collaborators
-
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Priyanka Sharma, MD · University of Kansas Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-22
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular Profiling in Prostate Cancer
NCT04983628 ·Status: UNKNOWN
-
BRCA1 Haploinsufficiency and Gene Expression
NCT00597987 ·Status: COMPLETED
-
Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System
NCT05306600 ·Status: RECRUITING
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
Clinical Significance of Germline BRCA Mutations
NCT00579488 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
NCT06274541 ·Status: COMPLETED
-
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
NCT02560818 ·Status: COMPLETED ·Phase: NA
-
Genetic Investigation of Cancer Predisposition
NCT04620278 ·Status: NOT_YET_RECRUITING
-
Genomic Profiling in Cancer Patients
NCT01775072 ·Status: RECRUITING
-
TREC@TAMU Cancer Prevention Registry and Repository
NCT06826014 ·Status: RECRUITING
-
Biomarker Monitoring in TP53 Mutation Carriers
NCT02289326 ·Status: COMPLETED
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Familial Cancer Registry and DNA Bank
NCT02083224 ·Status: UNKNOWN
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
NCT00588263 ·Status: WITHDRAWN
-
Prospective Registry of Multiplex Testing (PROMPT)
NCT02665195 ·Status: ACTIVE_NOT_RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
NCT02610413 ·Status: RECRUITING
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Prevalence of BRCA in Patients With Ovarian Cancer
NCT02222883 ·Status: COMPLETED
-
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
NCT02906943 ·Status: RECRUITING
-
Study on Fertility Parameters in Women With Germline Variants in BRCA1 and BRCA2
NCT06710015 ·Status: NOT_YET_RECRUITING
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA